Table 3.
Visit 1 | Visit 4 | |||||
---|---|---|---|---|---|---|
Persisting SBP (mean ± SEM) | Recovering SBP (mean ± SEM) | Persisting SBP > recovering SBP (t-score) | Persisting SBP (mean ± SEM) | Recovering SBP (mean ± SEM) | Persisting SBP > recovering SBP (t-score) | |
VAS (0–100) | 57.61 ± 4.12 | 52.93 ± 4.33 | 0.78 | 53.61 ± 6.13 | 27.77 ± 5.10 ↓ | 5.94** |
MPQ sensory | 12.42 ± 1.59 | 9.66 ± 1.05 | 1.43 | 11.50 ± 1.42 | 5.65 ± 1.37 ↓ | 2.96** |
MPQ affective | 3.05 ± 0.61 | 1.43 ± 0.51 | 1.44 | 3.20 ± 0.69 | 0.89 ± 0.42 ↓ | 3.43** |
MPQ radiulopathy | 5.6 ± 0.49 | 4.30 ± 0.50 | 1.80 | 5.30 ± 0.90 | 3.50 ± 0.73 ↓ | 2.48* |
NPS | 47.71 ± 4.25 | 34.4 ± 3.44 | 2.55* | 42.00 ± 4.78 | 16.53 ± 2.98 ↓ | 5.14** |
BDI | 6.45 ± 1.01 | 6.55 ± 1.32 | −0.05 | 6.06 ± 1.46 | 3.54 ± 1.17 ↓ | 1.25 |
PANAS positive | 33.05 ± 8.05 | 32.97 ± 1.89 | 0.03 | 29.73 ± 6.69 | 34.42 ± 1.90 | −1.9* |
PANAS negative | 19.4 ± 1.80 | 16.63 ± 1.44 | 1.32 | 20.07 ± 1.54 | 15.26 ± 2.39 ↓ | 2.40* |
Duration (weeks) | 12.4 ± 1.11 | 12.15 ± 1.08 | 0.15 | 65.93 ± 1.22 | 68.80 ± 1.10 | −0.70 |
Mean pain variance | 10.8 ± 3.29 | 10.8 ± 4.57 | 0.01 | 6.2 ± 1.89 | 1.52 ± 0.49 ↓ | 2.30* |
MQS | 1.91 ± 0.60 | 2.62 ± 0.68 | −0.71 | 3.71 ± 0.99 | 4.10 ± 0.99 | −0.25 |
MAD | 0.53 ± 0.41 | 0.51 ± 0.58 | 0.10 | 0.67 ± 0.53 | 0.41 ± 0.42 | 1.7 |
Clinical pain and mood parameters for persisting SBP (n = 21) and recovering SBP (n = 18) at visit 1 (within weeks from entry into study) and visit 4 (1 year after entry into study). Significant changes between visit 1 and visit 4 (paired t-test, P < 0.01) are displayed as increases (↑), or decreases (↓).
BDI = Beck Depression Index; MAD = mean absolute displacement (motion); MPQ = McGill Pain Questionnaire; MQS = Medication Quantification Scale; NPS = Neuropathic Pain Scale; PANAS = Positive Affect Negative Affect Scale; VAS = Visual Analogue Scale.
*P < 0.05 **P < 0.01, unpaired t-test. Data presented as mean ± SEM.